Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 11;12(11):1850.
doi: 10.3390/life12111850.

Atranorin, a Secondary Metabolite of Lichens, Exhibited Anxiolytic/Antidepressant Activity in Wistar Rats

Affiliations

Atranorin, a Secondary Metabolite of Lichens, Exhibited Anxiolytic/Antidepressant Activity in Wistar Rats

Nicol Urbanska et al. Life (Basel). .

Abstract

Atranorin (ATR) is one of lichens' many known secondary metabolites. Most current studies have investigated the various effects of ATR in vitro and only sporadically in vivo. The latest data indicate that ATR may have anxiolytic/antidepressive effects. This study aimed to analyze the potential of ATR in a depression-like state in male Wistar rats. Pregnant females were stressed by restricting their mobility in the final week of pregnancy three times a day for 45 min each, for three following days. After birth, progeny aged 60 days was stressed repeatedly. The male progeny was divided into three groups as follows: CTR group as a healthy control (n = 10), DEP group as a progeny of restricted mothers (n = 10), and ATR group as a progeny of restricted mothers, treated daily for one month with ATR (n = 10; 10 mg/kg of body weight, p.o.). Our results show that ATR acts as an antioxidant and markedly changes animal behavior. Concomitantly, hippocampal neurogenesis increases in the hilus and subgranular zone, together with the number of NeuN mature neurons in the hilus and CA1 regions. Our results indicate a potential antidepressant/anxiolytic effect of ATR. However, further studies in this area are needed.

Keywords: Wistar rats; anxiety; atranorin; depression; hippocampus; neurogenesis; reactive oxygen species; stress.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Rearing frequency (A) and the time spent in the open arms (B) in individual groups of control animals (CTR), depressive-like animals (DEP), and atranorin-treated animals (ATR) were evaluated using the elevated plus maze test. Values are presented as arithmetic mean ± SD. Significance is indicated by * p ˂ 0.05 and ** p ˂ 0.01.
Figure 2
Figure 2
The moving speed (A) and trajectory passed in the periphery (B) in individual groups of control animals (CTR), depressive-like animals (DEP), and atranorin-treated animals (ATR) evaluated in the open-field test. Values are presented as arithmetic mean ± SD. Significance is indicated by * p ˂ 0.05.
Figure 3
Figure 3
Brain weights (g) in individual groups of control animals (CTR), depressive-like animals (DEP), and atranorin-treated animals (ATR). Values are presented as arithmetic mean ± SD.
Figure 4
Figure 4
The number of proliferative Ki67-positive cells in the hilus (A) and subgranular zone (B) in individual groups of control animals (CTR), depressive-like animals (DEP), and atranorin-treated animals (ATR). Values are given as arithmetic mean ± SD. Significance is indicated by * p ˂ 0.05.
Figure 5
Figure 5
Number of NeuN-positive cells in the hilus (A), CA1 region (B), and granular cell layer (C) in individual groups of control animals (CTR), depressive-like animals (DEP), and atranorin-treated animals (ATR). Values are presented as arithmetic mean ± SD. Significance is indicated by ** p ˂ 0.01.
Figure 6
Figure 6
ACTH (A) and cortisol (B) levels in the blood of control animals (CTR), depressive-like animals (DEP), and atranorin-treated animals (ATR). Values are presented as arithmetic mean ± SD. Significance is indicated by * p ˂ 0.05, ** p ˂ 0.01, and *** p ˂ 0.001, respectively.
Figure 7
Figure 7
The level of reactive oxygen species in blood leukocytes in individual groups of control animals (CTR), depressive-like animals (DEP), and atranorin-treated animals (ATR). Values are presented as arithmetic mean ± SD. Significance is indicated by ** p ˂ 0.01 and *** p ˂ 0.01.

References

    1. Kessler R.C., Bromet E.J. The epidemiology of depression across cultures. Annu. Rev. Public Health. 2013;34:119. doi: 10.1146/annurev-publhealth-031912-114409. - DOI - PMC - PubMed
    1. Santomauro D.F., Herrera A.M.M., Shadid J., Zheng P., Ashbaugh C., Pigott D.M., Abbafati C., Adolph C., Amlag J.O., Aravkin A.Y. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398:1700–1712. doi: 10.1016/S0140-6736(21)02143-7. - DOI - PMC - PubMed
    1. Vaváková M., Ďuračková Z., Trebatická J. Markers of oxidative stress and neuroprogression in depression disorder. Oxidative Med. Cell. Longev. 2015;2015:898393. doi: 10.1155/2015/898393. - DOI - PMC - PubMed
    1. Barth J., Schumacher M., Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: A meta-analysis. Psychosom. Med. 2004;66:802–813. doi: 10.1097/01.psy.0000146332.53619.b2. - DOI - PubMed
    1. Lund C., Brooke-Sumner C., Baingana F., Baron E.C., Breuer E., Chandra P., Haushofer J., Herrman H., Jordans M., Kieling C. Social determinants of mental disorders and the Sustainable Development Goals: A systematic review of reviews. Lancet Psychiatry. 2018;5:357–369. doi: 10.1016/S2215-0366(18)30060-9. - DOI - PubMed

LinkOut - more resources